Next Article in Journal
COVID-19 Pneumonia and Gut Inflammation: The Role of a Mix of Three Probiotic Strains in Reducing Inflammatory Markers and Need for Oxygen Support
Next Article in Special Issue
Living with Advanced Breast Cancer: A Descriptive Analysis of Survivorship Strategies
Previous Article in Journal
Are the Stage and the Incidental Finding of Endometriosis Associated with Fallopian Tube Occlusion? A Retrospective Cohort Study on Laparoscopic Chromopertubation in Infertile Women
Previous Article in Special Issue
Upregulation of Endothelin-1 May Predict Chemotherapy-Induced Cardiotoxicity in Women with Breast Cancer
 
 
Review
Peer-Review Record

A Systematic Review and Meta-Analysis of the Clinical Use of Megestrol Acetate for Cancer-Related Anorexia/Cachexia

J. Clin. Med. 2022, 11(13), 3756; https://doi.org/10.3390/jcm11133756
by Yu Liang Lim 1,†, Seth En Teoh 2, Clyve Yu Leon Yaow 2, Daryl Jimian Lin 2, Yoshio Masuda 2, Ming Xuan Han 3, Wee Song Yeo 4 and Qin Xiang Ng 1,*,†
Reviewer 1: Anonymous
Reviewer 2:
J. Clin. Med. 2022, 11(13), 3756; https://doi.org/10.3390/jcm11133756
Submission received: 28 May 2022 / Revised: 22 June 2022 / Accepted: 23 June 2022 / Published: 28 June 2022
(This article belongs to the Special Issue Side Effects of Cancer Therapeutics in Clinical Practice)

Round 1

Reviewer 1 Report

The authors have conducted a meta-analysis to evaluate the potential clinical benefits of megestrol acetate in patients with cancer related anorexia.  This provides a significant update compared to prior reviews.  The main endpoint that could be evaluated was mean change in weight from this analysis.  Even with high dose treatment, weight loss was more common than weight gain and studies were insufficient to evaluate skeletal muscle endpoints or quality of life.  The authors concluded that megestrol acetate was not effective in providing improvement in anorexia in patients with advanced cancer.  While this information is not new, the authors have done an excellent job of tabulating each of the studies and their key findings, which is quite valuable to those in the field of anorexia and cachexia.   This information should also be helpful for those involved with guideline development for patients with anorexia or cachexia.  No suggestions for revision.

Author Response

Thank you for the very positive comments and encouragement!

Reviewer 2 Report

Authors report a complete and exaustive review concerning the use of megestrol acetate in cancer related anorexia. Prior to acceptation authors should use the term anorexia/cachexia instead of anorexia. Moreover, some point should be added to the paper concerning the importance that nutrition in cancer patients has gained to day as testified by the nutritional algorythm published in the last years 

Author Response

Thank you for the comments.

  1. We have now used the term "anorexia/cachexia" instead of "anorexia".
  2. We have added a comment in the introduction as per your suggestion, "Providing dietary counseling, nutritional support and nutritional therapies are therefore important and endorsed by major clinical practice guidelines (Arends et al., 2021)."

This manuscript is a resubmission of an earlier submission. The following is a list of the peer review reports and author responses from that submission.


Back to TopTop